GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Ringpu Bio-Technology Co Ltd (SZSE:300119) » Definitions » EBITDA Margin %

Tianjin Ringpu Bio-Technology Co (SZSE:300119) EBITDA Margin % : 17.60% (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Tianjin Ringpu Bio-Technology Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tianjin Ringpu Bio-Technology Co's EBITDA for the three months ended in Mar. 2025 was ¥145 Mil. Tianjin Ringpu Bio-Technology Co's Revenue for the three months ended in Mar. 2025 was ¥822 Mil. Therefore, Tianjin Ringpu Bio-Technology Co's EBITDA margin for the quarter that ended in Mar. 2025 was 17.60%.


Tianjin Ringpu Bio-Technology Co EBITDA Margin % Historical Data

The historical data trend for Tianjin Ringpu Bio-Technology Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Ringpu Bio-Technology Co EBITDA Margin % Chart

Tianjin Ringpu Bio-Technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 31.69 30.05 26.76 27.41 19.69

Tianjin Ringpu Bio-Technology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.15 20.33 18.89 5.71 17.60

Competitive Comparison of Tianjin Ringpu Bio-Technology Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Ringpu Bio-Technology Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Ringpu Bio-Technology Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Ringpu Bio-Technology Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Tianjin Ringpu Bio-Technology Co's EBITDA Margin % falls into.


;
;

Tianjin Ringpu Bio-Technology Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Tianjin Ringpu Bio-Technology Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=604.422/3069.933
=19.69 %

Tianjin Ringpu Bio-Technology Co's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=144.613/821.616
=17.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Ringpu Bio-Technology Co  (SZSE:300119) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Tianjin Ringpu Bio-Technology Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Tianjin Ringpu Bio-Technology Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Ringpu Bio-Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No.6, Liujing Road, Developing Zone, Tianjin, CHN, 300300
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company. It is engaged in biotechnology and animal medicine, focusing on the national demand for agricultural sustainable development. The company provides products for Poultry; Swine; Pet; Aquatic; and Cattle and Sheep.
Executives
You Yong Jun Executives
Xu Lei Directors, executives
Liang Zhao Ping Executives
Li Shou Jun Directors, executives
Bao En Dong Director
Wang Xing Zhong Securities Affairs Representative
Peng Yu Peng Supervisors
Sun Ming Executives
Liang Wu Directors, executives
Hu Wen Qiang Directors, executives
Xu Jian Securities Affairs Representative
Su Ya La Da Lai Supervisors
Li Xu Dong Directors, executives
Dai Jin Ping Director
Xie Yong Director

Tianjin Ringpu Bio-Technology Co Headlines

No Headlines